CoChat

Ivabradine in Combination With Metoprolol Succinate in the Treatment of Inappropriate Sinus Tachycardia

Ptaszynski, Pawel, Kaczmarek, Krzysztof, Ruta, Jan, Klingenheben, Thomas, Cygankiewicz, Iwona, Wranicz, Jerzy K. · 2013 · Journal of Cardiovascular Pharmacology and Therapeutics

The DOI matches its Crossref record; 22 of the 23 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Inappropriate sinus tachycardia (IST) is a clinical syndrome characterized by excessive resting heart rate (HR) or a disproportional increase in HR during exercise. β-blocker or calcium channel-blocker therapy is often noneffective or not well tolerated. The HR reduction on ivabradine is similar to β-blockers but in some patients its efficacy to resolve all IST-related symptoms is limited. The aim of the study was to assess the efficacy and safety of combining ivabradine with metoprolol succinate in patients with refractory highly symptomatic IST. METHODS: Twenty patients (36 ± 10 years; 16 women) with IST were enrolled. All patients received metoprolol succinate 95 mg single dose during the first month of the study. After 4 weeks of treatment with metoprolol, ivabradine was administered as adjuvant therapy up to 7.5 mg twice daily. Holter monitoring and treadmill stress test were performed at baseline, after 4, and 8 weeks of the study, respectively. RESULTS: We observed significant and similar reduction in resting HR both for metoprolol and for combined therapy compared to the baseline. The mean HR during daily activity was significantly lower on ivabradine and metoprolol compared to monotherapy with β-blocker. The combined treatment yielded a significant increase in exercise capacity as assessed by treadmill stress test. After 4 weeks of combined therapy a significant reduction in IST-related symptoms, measured by means of the European Heart Rhythm Association score, was observed. CONCLUSION: Combining ivabradine with metoprolol is an effective and well-tolerated treatment option for IST in patients with refractory to monotherapy.

Overview

Integrity signals

Registry

Crossref · 10.1177/1074248413478172

Cites

22 of 22 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Research works printed but not linked: 1

  1. Kaplinsky E, 2010, Cardiol J, 17, 166

Cited by

See all 60

Metadata

Authors
Ptaszynski, P., Kaczmarek, K., Ruta, J., Klingenheben, T., Cygankiewicz, I., & Wranicz, J. K.
Affiliations
  • Medical University of Lodz (PL)
  • Cardiology Practice Bonn, Bonn, Germany
Corresponding author
Ptaszynski, Pawel
Venue
Journal of Cardiovascular Pharmacology and Therapeutics
Published
2013-02-19
Volume
18
Issue
4
Pages
338-344
ISSN
  • 1074-2484 (ISSN-L)
  • 1940-4034
OpenAlex
W2122566237
Cited by
57
References
23
Citations by year
2025: 3 · 2024: 3 · 2023: 3 · 2022: 3 · 2021: 13 · 2020: 6 · 2019: 7 · 2018: 3 · 2017: 3 · 2016: 3 · 2015: 8 · 2013: 1
FWCI
2.72
Type
journal article
Language
en
Open access
closed
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • Journal of Cardiovascular Pharmacology and Therapeutics (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Heart rate and cardiovascular health
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Arrhythmias and Treatments
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
Keywords
inappropriate sinus tachycardia, ivabradine, metoprolol succinate, combination therapy, exercise capacity, symptom scores, adjuvant therapy
MeSH terms
Ivabradine, Adrenergic beta-Antagonists, Adult, Benzazepines, Drug Resistance, Drug Therapy, Combination, Exercise Test, Female, Humans, Male, Metoprolol, Middle Aged, Tachycardia, Sinus, Electrocardiography, Ambulatory, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.